A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia

Trial Profile

A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Jul 2018

At a glance

  • Drugs Bococizumab (Primary) ; Bococizumab (Primary)
  • Indications Hypercholesterolaemia
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 07 Nov 2012 Pooled analysis presented at the 85th Annual Scientific Sessions of the American Heart Association.
    • 29 Mar 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
    • 29 Mar 2012 Actual patients number is 49 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top